Pioglitazone for adults with high risk of developing type 2 diabetes mellitus

To assess the effects of pioglitazone for adults with high risk of developing type 2 diabetes, which includes impaired glucose tolerance (IGT), impaired fasting blood glucose (IFG) and glycosylated haemoglobin A1c (HbA1c) measurements 5.7% to 6.4%.

This is a protocol.

Share/Save